More Bioxyne Limited news
Bioxyne LimitedASX: BXN

BXN Awarded GMP Manufacturing License for Medical Cannabis

Feb 4, 2024 at 9:41 PM EST · Issued by Bioxyne Limited

Filed with ASX · Feb 4, 2024 at 9:41 PM EST · 3 pages · English

On 6ix: 6ix.com/news/bxn-awarded-gmp-manufacturing-license-for-medical-cannabis

Bioxyne Limited on 6ix

Earlier from Bioxyne

  • Retirement of DirectorNov 17, 2023
  • BLS Extends Amazon Footprint into US and JapanJul 17, 2023
  • BXN to Acquire Health & Wellness Co Breathe Life SciencesDec 18, 2022
  • Joins Asian Partner & Sells 49% of Direct Selling BusinessOct 23, 2022
  • Appendix 4D and Interim ReportFeb 22, 2022

Later from Bioxyne

  • BXN Manufactures First Pharmaceutical Cannabis GummiesAug 20, 2024
  • Response to ASX Query LetterAug 23, 2024
  • Suspension from Official QuotationSep 13, 2024
  • Announcement 21.8.2024 Clarifying StatementSep 17, 2024
  • Reinstatement to QuotationSep 17, 2024
All Bioxyne news releases↗

Follow Bioxyne into a list and get an email when it puts out news.

Follow Bioxyne
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer